After lung cancer, prostate cancer is the second cause of death in men over 65 years of age.
According to European statistics, currently one of every six men will be diagnosed with prostate cancer at some point during their life. Therefore, early detection plays a key role in increasing the probability of recovery.
Men with a genetic predispositions for prostate cancer: If a first-degree family member, such as the patient’s father, has had prostate cancer, the first screening is recommend starting at age 45.
Men who have no immediate family member who has suffered from cancer but require monitoring for their safety. Consultation with a urologist is recommended once a year.
To monitor the progress of the disease, the concentration of PSA, a prostate antigen, is measured from a serum sample. This substance is used as a biomarker or to monitor disease progression after treatment.
Dr. Fernández Montero, José Manuel
Jefe de la Unidad de Urología
Tel.: +34 952 908 628
952908898 Oncology
951829978 Diagnosis by imaging
951829947 Gynecology
952908897 Fertility
951829947 Physiotherapy
